Transcatheter Aortic Valve Replacement System Pivotal Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 878 participants.

Also called NCT02163850

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 878 participants (planned count) (from the registry)
Sponsor
Direct Flow Medical, Inc. (from the registry)
Registry
  • NCT NCT02163850
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02163850. Randomized; no masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transcatheter Aortic Valve Replacement System Pivotal Trial
Acronym
SALUS
Condition
Aortic Valve Stenosis
Intervention (Device)
Direct Flow Medical
Intervention (Device)
Commercially Available
Lead sponsor
Direct Flow Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02163850
Content hash
eefd77aca36c95bec2d0c44f63c7b25813797260b7a4207294ed0cb1a062b8cc